Healthcare & Biotech

Berlin – September 16, 2026 -- Aignostics has opened early access to PathoSearch, a visual search engine that retrieves diagnosed reference pathology cases from a single screenshot of an H&E slide, targeting the rare and complex cases that make up as much as 20% of a pathologist's caseload.

Database already spans 310,000 slides across 300 diagnostic entities

PathoSearch currently references more than 310,000 whole slide images drawn from over 35,000 cases, covering 300-plus diagnostic entities and 27-plus organs. The system is on track to exceed one million whole slide images by general availability. Coverage follows the WHO Classification of Tumours, focusing on malignant tumours across five organ groups -- thoracic, digestive, soft tissue and bone, female genital, and urinary and male genital -- with full coverage of all WHO-classified malignancies planned.

Boston – September 16, 2026 -- PerZeption Inc. has secured a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute to fund development of a new photostress recovery test for age-related macular degeneration (AMD), a condition affecting an estimated 20 million people in the United States.

NEI Funds Photostress Recovery Test for Earlier AMD Detection

The award backs the project "Efficient Achromatic and Chromatic Photostress Recovery Assessment for Age-related Macular Degeneration," which will be carried out in collaboration with researchers at the Brunson Center for Translational Vision Research at the University of California, Irvine. The work targets how quickly vision recovers after bright-light exposure, a marker of macular health that can reveal functional deficits before they show up on standard acuity tests.

Cordova, Tenn. – September 16, 2026 -- Aesthetic Management Partners (AMP) has added ATTIVA®, an intelligent subdermal radiofrequency platform developed by Italy's Tema Medicina S.R.L., to its aesthetic technology portfolio, the company announced.

ATTIVA delivers controlled thermal energy beneath the skin to remodel tissue

The platform uses a fine, insulated cannula to deliver radiofrequency energy into subdermal tissue, producing immediate collagen contraction while supporting progressive collagen and elastin regeneration. It targets the face, neck, jawline, submental area and body, and is designed as a minimally invasive option with limited downtime for most patients.

Plantation, Fla. – September 16, 2026 -- LUX Infusion has acquired two ambulatory infusion centers, South Jersey Pediatric and Adult Infusion Center in Cherry Hill, New Jersey, and Northeast Infusion Therapy in Latham, New York, expanding its clinician-led network into two new states.

LUX Infusion adds two ambulatory infusion centers to its national network

The Plantation, Florida-based company, a portfolio holding of Frazier Healthcare Partners, said the acquisitions extend its footprint of ambulatory infusion centers (AICs) focused on physician-ordered and medically prescribed infusion therapies.

South Jersey center serves both pediatric and adult patients in Cherry Hill

South Jersey Pediatric and Adult Infusion Center delivers physician-ordered infusion services in an outpatient setting serving both pediatric and adult populations, with emphasis on medical supervision and coordination with referring physicians.

Madison, Wis. – September 16, 2026 -- Accuray Incorporated (NASDAQ: ARAY) and RaySearch Laboratories AB (publ) have signed a definitive agreement expanding their collaboration to accelerate adoption of online adaptive radiation therapy, with Accuray committing to purchase RayStation software licenses valued at $8 million.

Accuray commits $8 million to RaySearch software licenses

Under the deal, Accuray will buy specified RayStation licenses to support commercialization of online adaptive radiation therapy solutions, which both companies will jointly market and support. The agreement also brings RaySearch's RayCare technology into the partnership to simplify connectivity between clinical systems and streamline adaptive workflows.

Toronto – September 16, 2026 -- iGan Partners, a Toronto-based venture capital firm focused on medical device, diagnostic, imaging, and digital health companies, disclosed a series of portfolio milestones, headlined by a development contract worth up to $70 million awarded to portfolio company Flosonics Medical.

Flosonics secures BARDA contract to extend ultrasound tech into trauma care

The contract, from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, includes approximately $15 million in initial funding. It supports FloPredict, an AI-enabled software enhancement to Flosonics' FDA-cleared FloPatch device, expanding the real-time ultrasound technology into trauma care and mass casualty response applications.

Oklahoma City – September 16, 2026 -- Acarix AB announced that a peer-reviewed study published in PLOS Digital Health found its seismocardiography (SCG) technology can detect heart failure with diagnostic accuracy comparable to NT-proBNP, the current standard blood test, while producing significantly fewer false positives.

SCG algorithm matches blood test accuracy with far higher specificity

Researchers at Aalborg University Hospital, Aarhus University Hospital and Odense University Hospital enrolled 218 patients, including 198 referred by general practitioners for suspected heart failure and 20 with previously confirmed HFrEF. Using machine learning, the team built two SCG-based scores: an 'AnyHF-score' to flag heart failure of any type, and an 'HFrEF-score' targeting the more severe reduced-ejection-fraction form of the condition.

Pensacola, Fla. – September 16, 2026 -- Lori Lee Barr, MD, FACR, FAIUM, a partner at Radiology Associates of Florida, P.A., has been named a 2026 Top Pinnacle Healthcare Professional by The Inner Circle for her work in radiology, the organization announced.

Dr. Barr holds dual board certification in pediatric and diagnostic radiology

Dr. Barr is a Diplomate of the American Board of Radiology, one of 24 specialty boards under the American Board of Medical Specialties. She earned her medical degree from Louisiana State University School of Medicine at Shreveport and completed her diagnostic radiology residency and pediatric radiology fellowship at the University of Texas Medical Branch at Galveston. The American College of Radiology and the American Institute of Ultrasound in Medicine have recognized her as a fellow for teaching, research, clinical care and community advocacy.

New York – September 16, 2026 -- A consensus paper published in Diabetologia establishes the first international framework for population-wide screening of type 1 diabetes (T1D), setting concrete age thresholds and testing protocols for clinical adoption.

Nearly 30 global experts define screening ages and intervals

The guidance, convened by Breakthrough T1D and developed by close to 30 international experts, recommends initial autoantibody screening for children aged 2-4 years. Children who test negative should be rescreened at ages 6-8 and again at 10-15, timed to align with routine preventative healthcare visits. Initial positive results require confirmation with a second test before diagnosis is made.

Little Rock, Arkansas – September 16, 2026 -- The American Association of Kidney Patients (AAKP) inducted Pine Bluff advocate Bob Abbott into its newly created Kidney Advocate Hall of Fame on September 10, opening the organization's 51st annual National Patient Meeting in Little Rock, Arkansas.

AAKP launches inaugural Hall of Fame class at Clinton Presidential Center

The induction ceremony took place during AAKP's Policy Forum session at the William J. Clinton Presidential Center, recognizing Abbott alongside medical experts, federal officials, and researchers as part of the Hall of Fame's first cohort. AAKP's tribute cited more than five decades of advocacy work by Abbott, owner and manager of Abbott Enterprises Inc. in Pine Bluff.